Overview

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy with Aktilite™ lamp in subjects with mild actinic keratoses (intra-individual comparison).

Phase:

Phase 3

Details

Lead Sponsor:

Galderma
Galderma R&D

Treatments:

Aminolevulinic Acid
Methyl 5-aminolevulinate